IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS

Tariq Ahmad  1     María Dolores Martín-Arranz  2     Brigitta Brinkman  3     Christopher Gasink  4     Meijian Guan  5     Amy Hart  6    
1 Nuffield Health Exeter Hospital, Exeter, United Kingdom
2 Hospital La Paz, Madrid, Spain
3 Janssen Pharmaceutica, Beerse, Belgium
4 Janssen Scientific Affairs, LLC, Horsham, United States
5 Janssen Research & Development, LLC, Spring House
6 Janssen Research & Development, LLC., Spring House

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing